{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T20:06:47Z","timestamp":1747166807024,"version":"3.40.5"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.leukres.2019.02.003","type":"journal-article","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T11:28:11Z","timestamp":1549970891000},"page":"3-5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Chronic myeloid leukemia: Two mysteries"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9701-1851","authenticated-orcid":false,"given":"Tomas","family":"Radivoyevitch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trine N.","family":"Jorgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaroslaw P.","family":"Maciejewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9156-1676","authenticated-orcid":false,"given":"Robert Peter","family":"Gale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2019.02.003_bib0005","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1182\/blood-2011-09-381855","article-title":"Quantitative modeling of chronic myeloid leukemia: insights from radiobiology","volume":"119","author":"Radivoyevitch","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2019.02.003_bib0010","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1667\/RR2892.1","article-title":"The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950-2001","volume":"179","author":"Hsu","year":"2013","journal-title":"Radiat. Res."},{"key":"10.1016\/j.leukres.2019.02.003_bib0015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.leukres.2017.03.003","article-title":"Is there immune surveillance against chronic myeloid leukaemia? Possibly, but not much","volume":"57","author":"Gale","year":"2017","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2019.02.003_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/v8010005","article-title":"HTLV-1, immune response and autoimmunity","volume":"8","author":"Quaresma","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.leukres.2019.02.003_bib0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cellimm.2015.02.001","article-title":"Sex disparities in the immune response","volume":"294","author":"Jorgensen","year":"2015","journal-title":"Cell. Immunol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212619300293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212619300293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T09:30:08Z","timestamp":1552383008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212619300293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":5,"alternative-id":["S0145212619300293"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2019.02.003","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic myeloid leukemia: Two mysteries","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2019.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}